FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/23/2022
Back to search
Official data from USPTO
NEUTRALISA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEUTRALISA
ST13
US500000079312507Class
1, 5, 9
Filing
79312507
Registration
6635236
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/23/2022
Trademark type
Word
Nice classes
1, 5, 9
Filing date
03/10/2021
Registration date
02/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/08/2022
Last transaction
02/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
DE
Examiner
HOLTZ, ALLISON
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EUROIMMUN Medizinische Labordiagnostika AG
Representatives
Kevan L. Morgan Seed IP Law Group LLP
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparationsother than for medical or veterinary use; diagnostic preparations and diagnostic substances for scientific purposesin particular immobilised proteinsnucleic acidsallergens and tissue sections on a carrier/a carrier materialin particular a biochipa microspherea paper ringa test stripa blotan (ELISA-) microtiter plate or a membrane
Class 5
Diagnostic preparationsin particular diagnostic preparations for medical and veterinary purposes for the detection of allergiesneurological diseasesmetabolic diseasesinfectious diseasesautoimmune diseasesfood intolerancescancer; diagnostic preparations for medical and veterinary purposes; diagnostic preparations for medical and veterinary purposesin particular immobilised proteinsnucleic acidsallergens and tissue sections on a carrier/a carrier materialin particular a biochipa microspherea test stripa blotan (ELISA-) microtiter plate or membrane; reagents for medical and veterinary diagnostic purposes; reagents for medical and veterinary diagnostic purposesin particular immobilised proteinsnucleic acidsallergens and tissue sections on a carrier/a carrier materialin particular a biochipa microspherea paper ringa test stripa blotan (ELISA-)microtiter plate or a membrane
Class 9
Measuringdetecting and monitoring instrumentsmeasuringdetecting and monitoring devicesmeasuringdetecting and monitoring regulators for preparingprocessing and evaluating diagnostic samples for detecting allergiesneurological diseasesmetabolic diseasesinfectious diseasesautoimmune diseasesfood intolerances and cancer; sensors and detectorsin particular UV fluorescence and chemiluminescence detectors for preparingprocessing and evaluating diagnostic samples; apparatus for recordingtransmitting or reproducing diagnostic datasound or imagesin particular camerasmicroscopesphotometersmicroplate photometersenzyme-linked immunosorbent assay readerschemiluminescence readersphotomultipliersmicroplate readers; downloadablerecorded or preinstalled softwarein particular downloadablerecorded or preinstalled laboratory software for analyzing laboratory test results
Publications
History of USPTO decisions and trademark events.
24 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/18/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
07/18/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2022
GPNX
NOTIFICATION PROCESSED BY IB
12/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/23/2021
PUBO
PUBLISHED FOR OPPOSITION
11/23/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/17/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/15/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/12/2021
RFNT
REFUSAL PROCESSED BY IB
09/11/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/23/2021
RFRR
REFUSAL PROCESSED BY MPU
08/23/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/20/2021
CNRT
NON-FINAL ACTION WRITTEN
08/19/2021
DOCK
ASSIGNED TO EXAMINER
08/19/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/03/2021
Continuous trademark protection
Get notified about every new filing that threatens NEUTRALISA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.